Skip to Content

NTRK1+NTRK2+NTRK3 (SDL12056)

https://www.scanlabglobal.com/web/image/product.template/6741/image_1920?unique=18393fc
Tests NTRK1/2/3 fusions in tumors for targeted therapy. Fusions guide entrectinib or larotrectinib for solid tumors or sarcomas.

3,990.00 AED 3990.0 AED 3,990.00 AED

3,990.00 AED

Not Available For Sale

This combination does not exist.